Site Specific Cancer Series: Gynecologic Cancers Online Course

Utilizing a combination of didactic content, case studies and interactive activities, this webcourse will provide nurses with the information they need to provide evidence-based care to women at risk for or undergoing treatment or long-term follow-up for gynecologic malignancies.

Categories: Patient Population/Adult, Prevention and Detection/Screening, Symptom Management/Long-term effects, Symptom Management/Psychosocial, Treatment/Chemotherapy/Biotherapy, Treatment/Radiation, Treatment/Surgery, Type of Cancer/Reproductive Cancers

FormatWebcourse
Contact Hours8.3
Member Price$99 course + eBook
Non-Member Price$139 course + eBook
Contacteducationcourses@ons.org
Technical RequirementsTechnical Requirements
Cancellation PolicyCancellation Policy

Upcoming Dates

No upcoming programs scheduled

Date Location Instructor Registration Deadline
10/07/2014 - 11/04/2014 ONS Online Courses 09/29/2014 11:59 PM

Participate

ONS is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.

ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850.

There is no sponsor for this course.

ONCC Certification Test Blueprint Topics and ILNA Content Areas

Course Objectives

 
Describe screening and management strategies for women at risk for gynecologic cancers.
Describe the impact of extent of disease on treatment and prognosis.
Identify key concepts in the management of patients undergoing surgery.
Outline a teaching plan for patients receiving radiation for cervical cancer.
Describe the safety issues that can arise with drug therapies for women with gynecologic cancer.
Outline the management of three common side effects of treatment gynecologic cancers.
Explain the impact of gynecologic cancers diagnosis on social role.
Identify resources that would be beneficial to a patient experiencing sexuality or fertility issues.
Identify the surveillance schema for women who have undergone treatment for gynecologic cancer.